Accessibility

A+ A A-

Information Accessibility Statement
Site Colors Display (* Modern browsers like Chrome & Firefox) Normal Display Adjusted for color blinded Adjusted for hard vision Close
image/svg+xml

#2022025 - Heart failure assistance

Leonid Sternik

Categories Medical device
Patent Status Pending

 

Background and Need

A left ventricular assist device (LVAD) is a mechanical pump that is implanted in patients with heart failure. It helps the bottom left chamber of the heart (left ventricle) pump blood out of the ventricle to the aorta and the rest of the body. The LVAD is implanted during an open heart surgery.

The common practice of implementing a cannula of left ventricular assist device (LVAD) to the left ventricle (LV) is through a large opening made in the apex of the LV, which has some disadvantages such as requirement of sternotomy, making a hole in an already very week left ventricle, requirement of cardiopulmonary bypass etc.

Heart failure (HF) is a global pandemic affecting at least 26 million people worldwide and is increasing in prevalence. Left ventricular assist devices (LVADs) as a bridge to transplant, a bridge to recovery, or a destination therapy have become standard of care for selected patients with advanced heart failure (HF). Their use has steadily increased, and since 2012 more than 2000 implants have been performed each year in the US. There is a need for a solution that does not require the use of the Heart-Lung Machine.  The present invention provides a solution for assisting cardiac circulation of a patient.


Invention

The present technology is a unique cannula allowing improved LVADs delivery and implementation.